Grant: Discovery Grants Program - Individual
University of Toronto
$36,000.00
Molecular Regulation of Alternative Splicing by Nuclear Receptors and Coregulators
FY 2013-14
Summary
The nuclear hormone receptors comprise a superfamily of ligand-activated transcription factors that regulate diverse physiological processes by coordinating patterns of gene expression. Transcriptional activation by a nuclear hormone receptor (NR) depends strongly on its interactions with coactivators and corepressors that either directly or indirectly modify the surrounding chromatin configuration to allow recruitment of the basal transcriptional machinery. While transcriptional activation or repression changes absolute levels of mRNA transcripts, an additional layer of complexity is created in the cell by the alternative splicing of the pre-messenger RNA. Much progress has been made in the field of alternative splicing through the study of RNA binding proteins which are important in reading the ""splicing code"", relatively little is known about how ligand-dependent transcriptional activation and alternative splicing are controlled in cells. Recently, we identified ARGLU1 as a glucocorticoid receptor (GR) coactivator and showed that it can affect splicing using in vitro mini-gene assays. Since, GR signaling has been a well studied paradigm for understanding of how nuclear receptors integrate environmental cues and translate them into changes in gene transcription, and ARGLU1 is a novel GR coactivator involved in splicing, we decided to uses these two proteins as a model to investigate cell-specific novel mechanisms of ligand-dependent transcriptional control. With recent advances in next generation sequencing technology we can now study the endogenous role of these NR binding proteins in alternative splicing. This research program will examine the molecular mechanisms by which members of the NR superfamily help promote transcriptional diversity by coordinating ligand-dependent transcriptional activation with alternative splicing. Because over 90% of human genes are estimated to undergo alternative splicing, understanding how nuclear receptors contribute to the transcriptional diversity at the molecular level is essential for understanding how NRs function in cell and tissue-specific contexts.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
356873-2013
Name nom
Cummins, Carolyn
Department département
Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5302
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene expression
Research subject fr
Expression génétique
Partie
1
Nb partie
1
Application title
Molecular Regulation of Alternative Splicing by Nuclear Receptors and Coregulators
Keyword
NSERC
Application summary
The nuclear hormone receptors comprise a superfamily of ligand-activated transcription factors that regulate diverse physiological processes by coordinating patterns of gene expression. Transcriptional activation by a nuclear hormone receptor (NR) depends strongly on its interactions with coactivators and corepressors that either directly or indirectly modify the surrounding chromatin configuration to allow recruitment of the basal transcriptional machinery. While transcriptional activation or repression changes absolute levels of mRNA transcripts, an additional layer of complexity is created in the cell by the alternative splicing of the pre-messenger RNA. Much progress has been made in the field of alternative splicing through the study of RNA binding proteins which are important in reading the ""splicing code"", relatively little is known about how ligand-dependent transcriptional activation and alternative splicing are controlled in cells. Recently, we identified ARGLU1 as a glucocorticoid receptor (GR) coactivator and showed that it can affect splicing using in vitro mini-gene assays. Since, GR signaling has been a well studied paradigm for understanding of how nuclear receptors integrate environmental cues and translate them into changes in gene transcription, and ARGLU1 is a novel GR coactivator involved in splicing, we decided to uses these two proteins as a model to investigate cell-specific novel mechanisms of ligand-dependent transcriptional control. With recent advances in next generation sequencing technology we can now study the endogenous role of these NR binding proteins in alternative splicing. This research program will examine the molecular mechanisms by which members of the NR superfamily help promote transcriptional diversity by coordinating ligand-dependent transcriptional activation with alternative splicing. Because over 90% of human genes are estimated to undergo alternative splicing, understanding how nuclear receptors contribute to the transcriptional diversity at the molecular level is essential for understanding how NRs function in cell and tissue-specific contexts.